Latest research: IBS

IBS: the latest science, from IBS-C to IBS-D

Irritable bowel syndrome (IBS) is a common, long-term condition that causes tummy pain, bloating and changes in bowel habit. Doctors now describe it as a disorder of gut-brain interaction, and it is grouped into types such as IBS-C (constipation) and IBS-D (diarrhoea) using the Bristol stool chart. Diet changes, medicines and gut-directed talking therapies all have research behind them, and recent UK trials have added new options.

Short on time? See what we recommend for gut health →

By The Gut Report editorial team. Updated . 10 minute read.

The short answer

  • IBS is now called a disorder of gut-brain interaction, meaning symptoms come from how the gut and brain communicate and work together.
  • IBS is grouped by your usual type of poo on the Bristol stool chart: IBS-C, IBS-D, IBS-M (mixed) or IBS-U (unclassified). About a third of people who still have IBS a year later have changed type.
  • First-line advice in the UK is regular meals, enough fluid, less caffeine, alcohol and fizzy drinks, and adjusting fibre. A low FODMAP diet can help, but it should be guided by a dietitian.
  • Gut-directed hypnotherapy and IBS-specific CBT are supported by UK guidelines, and newer trials suggest digital and nurse-led versions can help too.
  • The UK ATLANTIS trial (2023) found low-dose amitriptyline helped IBS symptoms more than a dummy pill when first-line treatments had not worked.
  • Faecal transplants and microbiome tests are still research tools for IBS, not routine care.

What is IBS?

Irritable bowel syndrome (IBS) is a common condition that affects the digestive system. The NHS describes the main symptoms as tummy pain or cramps that often ease after a poo, bloating, diarrhoea and constipation. Symptoms tend to come and go, and flare-ups can last days, weeks or months. It is usually a long-term condition, but diet changes and medicines can often help.

How common is IBS?

The British Dietetic Association says IBS affects around one in five adults, though figures depend on how IBS is defined. A 2021 Rome Foundation study of more than 73,000 adults in 33 countries found that 4.1% of people answering online met the stricter Rome IV definition, compared with 10.1% using the older Rome III rules.

Is IBS linked to the gut-brain axis?

Yes. The 2021 British Society of Gastroenterology (BSG) guideline describes IBS as "a disorder of gut-brain interaction". In plain terms, symptoms come from how the gut and brain communicate, including how sensitive the gut's nerves are.

This helps explain why treatments that act on the gut-brain link, such as gut-directed hypnotherapy, can ease gut symptoms. Read more in Stress and the gut-brain connection.

How is IBS diagnosed in the UK?

There is no single test for IBS. A GP makes the diagnosis from your symptoms and rules out other conditions.

NICE guidance (CG61) says IBS should be considered if you have had tummy pain or discomfort, bloating or a change in bowel habit for at least six months. The pain should be eased by a poo, or linked to a change in how often you go or what your poo looks like. NICE also looks for at least two of: straining, urgency or feeling you haven't finished; bloating or a swollen tummy; symptoms made worse by eating; and passing mucus.

To rule out other causes, NICE recommends blood tests including a full blood count, markers of inflammation and a test for coeliac disease. The NHS adds that a GP may test a poo sample for infection and inflammatory bowel disease (IBD). One such test is faecal calprotectin, which measures a protein linked to gut inflammation. NICE recommends it to help tell IBD and IBS apart in adults being considered for a specialist referral, when cancer isn't suspected.

NICE says tests such as colonoscopy and hydrogen breath tests aren't needed to confirm IBS when the criteria are met.

What are the types of IBS?

Doctors group IBS by your usual type of poo, using the Bristol stool chart. This seven-point scale runs from type 1 (hard lumps) to type 7 (watery). Under the Rome IV criteria, the type is based only on days when your poo isn't normal.

Type What it means Bristol stool pattern on abnormal days
IBS-C Mainly constipation More than a quarter types 1–2, less than a quarter types 6–7
IBS-D Mainly diarrhoea More than a quarter types 6–7, less than a quarter types 1–2
IBS-M Mixed More than a quarter types 1–2 and more than a quarter types 6–7
IBS-U Unclassified Meets IBS criteria but doesn't fit the groups above

Can your IBS type change?

Often, yes. A 2021 study followed people with IBS for 12 months. Among those who still had Rome IV IBS a year later, about a third (31.7%) had changed type. IBS-M was the least stable.

A 2026 study from a UK registry of people with IBS found the stool-based types were only moderately stable over a year. IBS-D was the steadiest, with 83% staying the same.

What is IBS-C?

IBS-C is IBS where constipation is the main problem. You may strain or feel you can't empty your bowels fully. UK guidance describes several approaches:

  • Fluids: the NHS suggests drinking plenty of water to soften poo, and at least 8 to 10 drinks of fluid a day overall.
  • Soluble fibre: NICE says any increase in fibre should be soluble, such as ispaghula (also called psyllium) or oats. The BSG guideline lists gradually increasing soluble fibre, and exercise, as first-line options.
  • Avoiding extra bran: NICE discourages insoluble fibre such as bran, and the BDA advises against eating extra wheat bran.
  • Laxatives: NICE says a GP may consider laxatives, though it discourages lactulose. The BSG guideline includes polyethylene glycol (a type of laxative). NICE suggests adjusting the dose to aim for a soft, well-formed poo (Bristol type 4).
  • Linaclotide: NICE says a GP may consider this prescription medicine if laxatives from different classes haven't helped and constipation has lasted at least 12 months.

What is IBS-D?

IBS-D is IBS where diarrhoea is the main problem, often with sudden urgency. Approaches in UK guidance include:

  • Diet: the NHS suggests cutting down on high-fibre foods such as wholegrains, nuts and seeds, and avoiding the sweetener sorbitol, found in some sugar-free sweets and gum. The BDA suggests limiting caffeine to three drinks a day.
  • Fluids: the NHS advises drinking plenty of water to avoid dehydration.
  • Loperamide: NICE names it as the first-choice medicine to slow the gut in IBS-D. It is available from pharmacies.
  • Other options a GP or specialist may consider: the BSG guideline describes ondansetron and rifaximin as second-line options. Both are licensed for other conditions but have shown benefits in IBS.

A 2023 review in Gut notes that tests can pick up bile acid diarrhoea, one cause of these symptoms.

What are IBS-M and IBS-U?

IBS-M means you regularly have both hard and loose poo. IBS-U means you meet the IBS criteria but your bowel habit doesn't fit neatly into a group.

NICE says medicine choices should be based on whichever symptoms are most troublesome. For tummy pain and cramps, NICE says a GP may consider antispasmodics (medicines that relax the gut muscle), taken when needed.

What causes IBS?

The exact cause isn't known. The NHS lists food passing through the gut too quickly or too slowly, a past bout of gastroenteritis, an oversensitive gut, stress and a family history of IBS.

  • Visceral hypersensitivity and gut motility: a 2023 review in Gut lists an extra-sensitive gut (where normal stretching or gas can hurt) and abnormal transit (food moving too fast or too slow) among the mechanisms behind IBS.
  • Post-infection IBS: a 2017 meta-analysis of 45 studies found that about 1 in 10 people had IBS a year after a gut infection. Women, people with anxiety or depression, and those given antibiotics during the illness were at higher risk.
  • Stress and mental health: the NHS lists stress and anxiety as triggers for flare-ups. A 12-year study found the link runs both ways. Anxiety predicted new gut symptoms later, and gut symptoms predicted more anxiety and low mood later.
  • The microbiome: a 2019 systematic review found differences in some gut bacteria between people with and without IBS. But it couldn't say whether these differences cause IBS or result from it. This is an active area of research with no firm answers yet.
  • Food triggers: the NHS lists alcohol, caffeine, and spicy or fatty foods as common triggers. The BDA notes that IBS is not caused by food allergy.

What should you eat with IBS?

First-line diet advice

NICE, the NHS and the BDA give similar starting advice:

  • Eat regular meals, and take time to eat.
  • Drink at least 8 cups of fluid a day, mainly water or other non-caffeinated drinks.
  • Limit tea and coffee to 3 cups a day.
  • Cut down on alcohol and fizzy drinks.
  • Limit fresh fruit to 3 portions (80g each) a day.
  • Cut down on fatty, spicy or processed foods.
  • If you have wind and bloating, try oats and up to 1 tablespoon of linseeds a day.

The BDA suggests keeping a food and symptom diary and making one change at a time.

Soluble or insoluble fibre?

NICE advises against insoluble fibre, such as bran, for IBS. Any increase should be soluble fibre: the NHS lists oats, pulses, carrots, peeled potatoes and linseeds, and NICE mentions ispaghula.

The low FODMAP diet

FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides and polyols. These are types of carbohydrate (sugars and starches) that gut bacteria can ferment.

A 2018 review by UK dietitians describes three stages:

  1. Restriction: cutting out high-FODMAP foods for a short period.
  2. Reintroduction: bringing FODMAP groups back one at a time to find your triggers.
  3. Personalisation: a longer-term, less restrictive diet that avoids only your own triggers.

NICE says the diet should only be given by a healthcare professional with expertise in diet, such as a dietitian. The BDA suggests asking your GP for a referral to an NHS dietitian if first-line changes haven't helped.

A 2022 network meta-analysis of 13 trials found the low FODMAP diet ranked first for easing overall IBS symptoms. Most of these trials were in hospital clinics, and few tested the reintroduction stage.

Peppermint oil

Peppermint oil is a pharmacy medicine that may relax the gut muscle. The NHS lists it among options to ask a pharmacist about for bloating and cramps. A 2022 meta-analysis of 10 trials found it eased overall symptoms and tummy pain more than a dummy pill. However, side effects were more common and the quality of evidence was very low. A summary of the BSG guideline notes that recent studies have questioned its effect.

Do talking therapies help IBS?

Yes, for many people. They don't mean IBS is "all in your head"; they work on the gut-brain link.

  • Gut-directed hypnotherapy uses hypnosis focused on gut symptoms. It is usually a course of sessions over several weeks, one-to-one or in a group.
  • IBS-specific CBT (cognitive behavioural therapy) is a talking therapy that looks at how thoughts, feelings and habits affect symptoms.

The BSG guideline strongly recommends both. It says they can be offered after 12 months of medicines haven't helped, or earlier depending on your preference and what is available locally. NICE suggests considering them when symptoms continue after 12 months of medicines.

Recent trials are encouraging:

  • The UK ACTIB trial (2019) found CBT by phone or online improved IBS symptoms more than usual care, with benefits lasting 12 months.
  • A 2025 Swedish study of nurse-led gut-directed hypnotherapy found about 62% of those who completed follow-up still had a meaningful improvement two years later.
  • A 2025 trial found a 42-session app-based hypnotherapy programme helped 81% of people, compared with 63% on a comparison programme.

Access varies across the UK, so ask your GP. In England, you can refer yourself to NHS Talking Therapies, which the NHS says may help people with anxiety or depression alongside a long-term condition such as IBS.

What's the latest IBS research?

Low-dose amitriptyline (ATLANTIS, 2023)

Amitriptyline is a tricyclic antidepressant. In IBS it is used at low doses as a "gut-brain neuromodulator", acting on nerve signals between gut and brain. NICE already suggests GPs consider it when first-line treatments haven't helped.

The ATLANTIS trial, published in The Lancet in 2023, tested this in 463 people at 55 GP practices in England. People started on 10 mg once a day and could adjust the dose up to 30 mg. After six months, symptoms improved more with amitriptyline than with a dummy pill. About 13% stopped amitriptyline because of side effects, compared with 9% on the dummy pill. The researchers concluded GPs should offer it, with support, when first-line treatments haven't worked. It's a decision to make with your GP.

Diet versus medicines (CARIBS, 2024)

A Swedish trial of 294 adults with moderate to severe IBS compared two diets with medicines chosen for each person's main symptom. After four weeks, symptoms improved meaningfully in 76% of people on a low FODMAP diet combined with NICE-style advice, and 71% on a lower-carbohydrate diet. The figure was 58% for medicines. In this single-centre trial, both diets did better than medicines over four weeks.

Faecal transplants: still experimental

A faecal microbiota transplant (FMT) moves stool from a healthy donor into another person's gut. A 2026 meta-analysis of 13 trials found very low certainty evidence that it helps IBS. For now, it is a research question for IBS rather than an established treatment.

Microbiome tests

Home gut microbiome tests are widely sold. A 2025 international expert consensus found there isn't enough evidence to recommend routine microbiome testing, and that direct-to-consumer tests have no proven clinical value. They are not part of diagnosing IBS.

When should you see a GP?

The NHS suggests seeing a GP if you think you have IBS and symptoms have lasted more than four weeks, or if diet changes and pharmacy medicines aren't helping.

Ask for an urgent GP appointment, or contact NHS 111, if you have:

  • lost a lot of weight for no reason
  • bleeding from your bottom or bloody diarrhoea
  • a hard lump or swelling in your tummy
  • shortness of breath, noticeable heartbeats (palpitations) and paler skin than usual

The BDA also advises talking to your doctor if you have a family history of bowel or ovarian cancer, or if you are over 60 and your poo has become looser or more frequent for more than six weeks.

The NHS notes there's no single diet or medicine that works for everyone. It can take time to find the mix that suits you, and support is there to help.

This is general information, not medical advice. See a GP if your symptoms are new, severe or getting worse, or if you notice blood in your poo or lose weight without trying. Don’t stop or change a prescribed medicine without speaking to your GP or pharmacist.

Questions people ask

What is the difference between IBS-C and IBS-D?
It depends on your usual poo on days when it isn't normal. In IBS-C, more than a quarter of those poos are hard or lumpy (Bristol types 1 or 2). In IBS-D, more than a quarter are loose or watery (types 6 or 7).
Can IBS change from constipation to diarrhoea?
Yes. In a 12-month study, IBS type changed in about a third of people who still had IBS a year later. Mixed IBS (IBS-M) was the type most likely to change.
Is IBS caused by stress?
Not on its own. Stress and anxiety can trigger flare-ups, and a 12-year study found the link runs both ways: anxiety can come before gut symptoms, and gut symptoms can lead to anxiety. Gut sensitivity, gut movement, past infections and food all play a part too.
Does the low FODMAP diet work for IBS?
A 2022 review of 13 trials found it ranked first for easing overall IBS symptoms compared with other diets studied. It is a short-term, three-stage plan rather than a diet for life, and UK guidance says it should be supported by a dietitian or other expert.
What tests confirm IBS?
There is no single test for IBS. A GP diagnoses it from your symptoms and usually arranges blood tests, including one for coeliac disease, and may test a poo sample for inflammation (faecal calprotectin) to rule out inflammatory bowel disease.

Sources

  1. What is IBS (irritable bowel syndrome). NHS, 2025
  2. Symptoms of IBS (irritable bowel syndrome). NHS, 2025
  3. Getting diagnosed with IBS (irritable bowel syndrome). NHS, 2025
  4. Diet, lifestyle and medicines for IBS (irritable bowel syndrome). NHS, 2025
  5. Irritable bowel syndrome in adults: diagnosis and management (CG61). NICE, 2017
  6. Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (HTG320, formerly DG11). NICE, 2013
  7. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut (Vasant DH et al.), 2021
  8. Practical, multidisciplinary, and evidence-based: updated BSG guidelines on the management of IBS. Gut blog (BMJ), 2021
  9. British Society of Gastroenterology guidelines for the management of irritable bowel syndrome (summary). American Family Physician (Ebell MH), 2022
  10. Irritable bowel syndrome (IBS) and diet: food fact sheet. British Dietetic Association, 2022
  11. Rome IV criteria. Rome Foundation
  12. Worldwide prevalence and burden of functional gastrointestinal disorders: results of Rome Foundation Global Study. Gastroenterology (Sperber AD et al.), 2021
  13. Symptom stability in Rome IV vs Rome III irritable bowel syndrome. American Journal of Gastroenterology (Barberio B et al.), 2021
  14. Stability of classification systems for irritable bowel syndrome. Alimentary Pharmacology & Therapeutics (Khasawneh M et al.), 2026
  15. Irritable bowel syndrome: treatment based on pathophysiology and biomarkers. Gut (Camilleri M, Boeckxstaens G), 2023
  16. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology (Klem F et al.), 2017
  17. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (Koloski NA et al.), 2012
  18. Gut microbiota in patients with irritable bowel syndrome: a systematic review. Gastroenterology (Pittayanon R et al.), 2019
  19. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. Journal of Human Nutrition and Dietetics (Whelan K et al.), 2018
  20. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut (Black CJ, Staudacher HM, Ford AC), 2022
  21. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS). Lancet Gastroenterology & Hepatology (Nybacka S et al.), 2024
  22. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics (Ingrosso MR et al.), 2022
  23. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS). The Lancet (Ford AC et al.), 2023
  24. Assessing telephone-delivered and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB). Gut (Everitt HA et al.), 2019
  25. Nurse-administered gut-directed hypnotherapy for irritable bowel syndrome: a two-year follow-up study. United European Gastroenterology Journal (Lövdahl J et al.), 2025
  26. Comparison of digitally delivered gut-directed hypnotherapy program with an active control for irritable bowel syndrome. American Journal of Gastroenterology (Anderson EJ et al.), 2025
  27. Find NHS talking therapies for anxiety and depression. NHS, 2025
  28. Fecal microbiota transplantation for symptom improvement in patients with irritable bowel syndrome: systematic review and meta-analysis of randomized controlled trials. Gastroenterology (Aumpan N et al.), 2026
  29. International consensus statement on microbiome testing in clinical practice. Lancet Gastroenterology & Hepatology (Porcari S et al.), 2025